Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 1:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 64 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard translation Clear all

Conditions: Cutaneous Lupus Erythematosus
Interventions: IVIg; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Irvine, California

Conditions: Health Knowledge, Environmental Exposure, Attitude, Practice
Interventions: Community-Centered Design Curriculum with EJT, Traditional Technical Curriculum; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 14 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Participation
Interventions: Recruitment nudges; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Muscle Disuse, Muscle Disuse Atrophy
Interventions: 20 grams protein, 40 grams protein; Dietary Supplement
Lead sponsor: United States Army Research Institute of Environmental Medicine; Federal
Eligibility: 17 Years to 39 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Natick, Massachusetts

Conditions: PreDiabetes
Interventions: Online diabetes prevention program, Standard Care; Behavioral
Lead sponsor: Omada Health, Inc.; Industry
Eligibility: 19 Years and older
Enrollment: 598 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Post-Traumatic Stress Disorder in Adolescence, Post Traumatic Stress Disorder
Interventions: Primary Care Intervention for PTSD Spanish Speaking Adolescents, Waitlist Treatment as Usual; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 12 Years to 22 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Peripheral Vascular Diseases
Interventions: Not listed
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Physical Inactivity, Vascular Dysfunction, Skeletal Muscle Atrophy
Interventions: Sauna, Reduced Physical Activity; Device · Behavioral
Lead sponsor: Brigham Young University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Provo, Utah

Conditions: Prostate Cancer
Interventions: Restricted Spectrum Imaging-Magnetic Resonance Imaging (RSI-MRI); Other
Lead sponsor: University of California, San Diego; Other
Eligibility: Male only
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Parkinson Disease
Interventions: Osteopathic Manipulative Treatment (OMT), Light Touch; Procedure · Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Cancer, Inflammatory Disease, Vascular Diseases, Metabolic Bone Disease
Interventions: PHOTON COUNTING CT Scanner; Device
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cancer
Interventions: Standardized Meals for Diet Stabilization, Forticare, Product 4808; Behavioral · Dietary Supplement
Lead sponsor: University of Arkansas; Other
Eligibility: 40 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Triple-Negative Breast Cancer (TNBC)
Interventions: BreakVax, Ipilimumab 2.5 mg, Pembrolizumab, Standard-of-care chemotherapy, Losartan and aspirin; Drug
Lead sponsor: BreakBio Corp; Industry
Eligibility: 18 Years to 72 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Breast Cancer, Invasive Breast Cancer, Carcinoma in Situ of the Breast
Interventions: Tissue Sample collection, Blood Sample Collection, Rectal Swab; Procedure · Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Coronary Artery Disease
Interventions: Ga-68 Galmydar, 13N-ammonia; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 99 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Chronic Disease, Cardiovascular Diseases
Interventions: Workplace-tailored CDSMP, Chronic Disease Self-Management Program; Behavioral
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 70 Years
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 13
States / cities: Danielsville, Georgia • Moultrie, Georgia • Valdosta, Georgia

Conditions: Multiple Myeloma
Interventions: CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs), Standard of care; Biological · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Limited English Proficiency, Perioperative Care
Interventions: Extended translation, Standard translation; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pregnancy Related
Interventions: Exercise in Pregnancy; Behavioral
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Neurocognition
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Smoking, Smoking Cessation, Tobacco Smoking, Cigarette Smoking
Interventions: Varenicline 0.5 MG, Nicotine Replacement Therapy (NRT); Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 652 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Obesity, Gestational Diabetes, Lifestyle, Healthy, Glucose Intolerance During Pregnancy, PreDiabetes, Hyperglycemia
Interventions: In-person health coach delivery of the GLB, Technology-assisted health coach delivery of the GLB; Behavioral
Lead sponsor: Tulane University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 722 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Traumatic Brain Injury
Interventions: Computerized clinical decision support; Other
Lead sponsor: Columbia University; Other
Eligibility: Not listed
Enrollment: 28,669 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Severe Malaria, Thrombocytopenia
Interventions: Whole blood transfusion; Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 1 Month to 59 Months
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus

Planetary Health and Environmental Justice in Construction Career Education

Using Nudges to Recruit for Health-Related Research

Muscle Response to Different Amounts of Dietary Protein During Leg Immobilization

Preventing Diabetes With Digital Health and Coaching

Adaptation of the PCIP for Spanish Speaking Adolescents and Families

MRI Guided Management of Occlusive Peripheral Arterial Disease

Heat Therapy During Reduced Physical Activity

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

Effects of Osteopathic Manipulative Treatment (OMT) on Gait Biomechanics in Parkinson's Disease

Translational Development of Photon-counting CT Imaging

Effects of Nutritional Supplementation (Product 4808) on Acute Skeletal Muscle Protein Synthesis in Cancer Patients

Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy

Prospective Breast Cancer Biospecimen Collection

Myocardial Perfusion Imaging Galmydar Rest/Stress

Putting CDSMP to Work

CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Translating Anesthesia Care Throughout

Community Translation of the Expecting Study

Translational Research Evaluating Neurocognitive Memory Processes

STARS (Smoking Treatment And Remote Sampling) Study

Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics

Traumatic Brain Injury - Knowledge Translation

Platelet-Directed Whole Blood Transfusion Strategy for Malaria